The focus of this Conference will be on biomarker research and its clinical application, molecular diagnostics, technological breakthroughs and artificial intelligence leading to a “New Era of Biomarkers in Oncology” and improving diagnosis, therapy monitoring and patient care through the course of cancer disease.
The Conference aims to bring together leading academic scientists, young and experienced researchers, medical clinicians and technology specialists from all fields of oncology to exchange and share their research results and experiences with emphasis on new biomarkers, technologies and applications in cancer care.
Oral and poster presentations, roundtable discussions and special topic seminars, workshops and room for interaction with colleagues and industry partners will provide new insights, constructive discussions and opportunities for networking and further collaborations.
Key topics of the conference include:
• Molecular pathology and blood-based biomarkers
• Liquid profiling / liquid biopsy: ctDNA, CTCs, Epigenetics, Fragmentomics
• Protein-based markers, tumor markers
• Extracellular vesicles and associated markers
• Immune diagnostics
• Microbiome
• Proteomics and Metabolomics
• Technological breakthroughs
• Evidence based medicine (EBM)
• Quality assurance, standardization and harmonization
• Preanalytical and analytical validation
• Organ-related biomarkers (solid cancers)
• Hematological cancers
• Early cancer detection and screening
• Prognostic and predictive biomarkers
• Monitoring of therapy response and toxicity
• Targeted and immune therapies, cancer vaccines
• Imaging technologies
• Advanced biostatistics and algorithms
• Digital biomarkers
• Artificial intelligence and machine learning
• Large language model diagnostics
• Clinical biomarker trials
• Biobanking and sample collections
• Personalized medicine: genomics/epigenetics/proteomics
• Multimodal diagnostics – individual modelling
• Cardio-Oncology